✦ LIBER ✦

PDB17 ECONOMIC ASSESSMENT OF ADD-ON THERAPY WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH DYSLIPIDEMIA AND TYPE-2 DIABETES IN GERMANY AND SWEDEN

✍ Scribed by W Berger; S Roze; AJ Palmer; WJ Valentine; D Liens; C Renaudin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB18 COST-EFFECTIVENESS OF ADD-ON PROLO

✍ B Paschen; S Roze; AJ Palmer; WJ Valentine; D Liens; C Renaudin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PCV31 HEALTH ECONOMIC ASSESSMENT OF RAIS

✍ C Renaudin; D Liens; AJ Palmer; WJ Valentine; W Berger; S Roze 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCV69 COST-EFFECTIVENESS OF ADD-ON THERA

✍ S Roze; WJ Valentine; ME Minshall; AJ Palmer; D Liens; C Renaudin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PDB8 CLINICAL BENEFITS OF PROLONGED-RELE

✍ D Liens; S Roze; WJ Valentine; ME Minshall; AJ Palmer; C Renaudin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCV17 PROJECTED IMPACT ON CORONARY HEART

✍ D Liens; AJ Palmer; WJ Valentine; C Renaudin; S Roze 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PDB9 PROJECTED IMPACT ON CORONARY HEART

✍ C Renaudin; S Roze; AJ Palmer; WJ Valentine; ME Minshall; D Liens 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB